Stocktaking and reconciliation of COVID-19 Vaccine Moderna at PCN designated sites

Sue Dickinson, Director of Pharmacy, Regional Drug & Therapeutics Centre (Newcastle)Published Last updated See all updates

Standard Operating Procedure for stocktaking and reconciliation of Moderna Spikevax® COVID-19 Vaccine from PCN designated sites to end user locations.


A standard operating procedure is attached to this page.

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in community pharmacy settings


Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. Current content still accurate
  1. The name of the vaccine has changed to Spikevax®
  2. Section 4.3 removal of outdated Foundry codes
  1. Published